D.YangC
An entirely new research program: characterization of the blends stability and pharmacokinetics, controlled animal studies of the combination with appropriate endpoints, factorial experiments to test for genuine synergy, and eventually adequately powered, randomized, placebo-controlled human trials with predefined outcomes and safety monitoring conducted under regulatory oversight
However, for those who do, studies have shown that DOACs may be advantageous over warfarin
However, this pattern was consistent across patients taking Tonmya and those taking a placebo, and as such may have been due to factors outside of the study
One main difference between the two is the site of action, where their effects are mostly localized
Advanced Handling Storage optimisation: Use desiccants, log temperatures, avoid fluctuations